Bluejay Diagnostics, Inc. financial data

Symbol
BJDX on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
360 Massachusetts Avenue, Suite 203, Acton, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 249 % -73.1%
Debt-to-equity 49.4 % +261%
Return On Equity -218 % -184%
Return On Assets -146 % -116%
Operating Margin -3.74K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.69M shares -86.9%
Common Stock, Shares, Outstanding 2.69M shares -86.9%
Entity Public Float 3.03M USD -85.8%
Common Stock, Value, Issued 269 USD -86.9%
Weighted Average Number of Shares Outstanding, Basic 2.36M shares +132%
Weighted Average Number of Shares Outstanding, Diluted 2.36M shares +132%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 249K USD
Research and Development Expense 5.69M USD +18.3%
Selling and Marketing Expense 619K USD +103%
General and Administrative Expense 4.22M USD -8.6%
Operating Income (Loss) -10.1M USD -1.32%
Nonoperating Income (Expense) 317K USD +200%
Net Income (Loss) Attributable to Parent -9.74M USD +0.82%
Earnings Per Share, Basic -7.58 USD/shares +34.7%
Earnings Per Share, Diluted -7.58 USD/shares +34.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.66M USD -60.8%
Inventory, Net 671K USD
Assets, Current 3.45M USD -61.2%
Property, Plant and Equipment, Net 1.3M USD -14.4%
Operating Lease, Right-of-Use Asset 299K USD -31.1%
Other Assets, Noncurrent 25.2K USD -24.6%
Assets 5.08M USD -53.4%
Accounts Payable, Current 272K USD -30%
Employee-related Liabilities, Current 534K USD +238%
Accrued Liabilities, Current 1.11M USD +28.3%
Liabilities, Current 1.53M USD +7.44%
Operating Lease, Liability, Noncurrent 171K USD -41.1%
Other Liabilities, Noncurrent 11.4K USD -23.8%
Liabilities 1.71M USD -1%
Retained Earnings (Accumulated Deficit) -29.3M USD -49.9%
Stockholders' Equity Attributable to Parent 3.37M USD -63.3%
Liabilities and Equity 5.08M USD -53.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.3M USD +21.7%
Net Cash Provided by (Used in) Financing Activities 2.78M USD
Net Cash Provided by (Used in) Investing Activities -35.4K USD +89.6%
Common Stock, Shares Authorized 7.5M shares -92.5%
Common Stock, Shares, Issued 2.69M shares -86.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.93M USD -149%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.66M USD -60.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 364 USD -99.8%
Deferred Tax Assets, Valuation Allowance 7.69M USD +66.2%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 7.69M USD +66.2%
Operating Lease, Liability 317K USD -35.7%
Depreciation 19.7K USD -83.6%
Payments to Acquire Property, Plant, and Equipment 35.4K USD -89.6%
Lessee, Operating Lease, Liability, to be Paid 346K USD -37.9%
Property, Plant and Equipment, Gross 2.56M USD +14.7%
Operating Lease, Liability, Current 146K USD -13.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 100K USD -38.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 100K USD -40.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 29.3K USD -54.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 25K USD -75%
Deferred Tax Assets, Operating Loss Carryforwards 4.55M USD +49.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 25K USD -75%
Operating Lease, Payments 44.2K USD +1.49%
Additional Paid in Capital 28.7M USD +1.48%
Share-based Payment Arrangement, Expense -18.5K USD -104%